Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain
European Journal of Clinical Microbiology & Infectious Diseases · 2024-02 · 43 (2) · 279-296
DOI: 10.1007/s10096-023-04697-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, online erschienen am 02.12.2023. Verfasst von Marta Hernández-García und 12 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. martahernandez1986@…. Hauptthemen laut MEDLINE: Carbapenems, Anti-Bacterial Agents, Bacterial Proteins, Borinic Acids. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Instituto de Salud Carlos III.
Abstract (Originalsprache)
PURPOSE: To characterize the resistance mechanisms affecting the cefepime-taniborbactam combination in a collection of carbapenemase-producing Enterobacterales (CPE) and carbapenem-resistant Pseudomonas spp. (predominantly P. aeruginosa; CRPA) clinical isolates. METHODS: CPE (n = 247) and CRPA (n = 170) isolates were prospectively collected from patients admitted to 8 Spanish hospitals. Susceptibility to cefepime-taniborbactam and comparators was determined by broth microdilution. Cefepime-taniborbactam was the most active agent, inhibiting 97.6% of CPE and 67.1% of CRPA (MICs ≤ 8/4 mg/L). All isolates with cefepime-taniborbactam MIC > 8/4 mg/L (5 CPE and 52 CRPA) and a subset with MIC ≤ 8/4 mg/L (23 CPE and 24 CRPA) were characterized by whole genome sequencing. RESULTS: A reduced cefepime-taniborbactam activity was found in two KPC-ST307-Klebsiella pneumoniae isolates with altered porins [KPC-62-K. pneumoniae (OmpA, OmpR/EnvZ), KPC-150-K. pneumoniae (OmpK35, OmpK36)] and one each ST133-VIM-1-Enterobacter hormaechei with altered OmpD, OmpR, and OmpC; IMP-8-ST24-Enterobacter asburiae; and NDM-5-Escherichia coli with an YRIN-inserted PBP3 and a mutated PBP2. Among the P. aeruginosa (68/76), elevated cefepime-taniborbactam MICs were mostly associated with GES-5-ST235, OXA-2+VIM-2-ST235, and OXA-2+VIM-20-ST175 isolates also carrying mutations in PBP3, efflux pump (mexR, mexZ) and AmpC (mpl) regulators, and non-carbapenemase-ST175 isolates with AmpD-T139M and PBP3-R504C mutations. Overall, accumulation of these mutations was frequently detected among non-carbapenemase producers. CONCLUSIONS: The reduced cefepime-taniborbactam activity among the minority of isolates with elevated cefepime-taniborbactam MICs is not only due to IMP carbapenemases but also to the accumulation of multiple resistance mechanisms, including PBP and porin mutations in CPE and chromosomal mutations leading to efflux pumps up-regulation, AmpC overexpression, and PBP modifications in P. aeruginosa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain. martahernandez1986@gmail.com.
- CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain. martahernandez1986@gmail.com.
- Servicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
- CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
- Servicio de Microbiología, Hospital Universitario A Coruña and Instituto de Investigación Biomédica A Coruña (INIBIC), A Coruña, Spain.
- Servicio de Microbiología, Hospital Universitario Marqués de Valdecilla and Instituto de Investigación Sanitaria Valdecilla (IDIVAL), Santander, Spain.
Förderung
- Instituto de Salud Carlos III
Zitieren
APA
Hernández-García, M., García-Castillo, M., Nieto-Torres, M., Bou, G., Ocampo-Sosa, A., Pitart, C., Gracia-Ahufinger, I., Mulet, X., Pascual, Á., Tormo, N., Oliver, A., Ruiz-Garbajosa, P., & Cantón, R. (2024). Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain. European Journal of Clinical Microbiology & Infectious Diseases, 43(2), 279-296. https://doi.org/10.1007/s10096-023-04697-4
Vancouver
Hernández-García M, García-Castillo M, Nieto-Torres M, Bou G, Ocampo-Sosa A, Pitart C, et al. Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain. European Journal of Clinical Microbiology & Infectious Diseases. 2024;43(2):279-296. doi:10.1007/s10096-023-04697-4
BibTeX
@article{HernndezGarca2024,
author = {Hernández-García, Marta and García-Castillo, María and Nieto-Torres, Marta and Bou, Germán and Ocampo-Sosa, Alain and Pitart, Cristina and Gracia-Ahufinger, Irene and Mulet, Xavier and Pascual, Álvaro and Tormo, Nuria and Oliver, Antonio and Ruiz-Garbajosa, Patricia and Cantón, Rafael},
title = {Deciphering mechanisms affecting cefepime-taniborbactam in vitro activity in carbapenemase-producing Enterobacterales and carbapenem-resistant Pseudomonas spp. isolates recovered during a surveillance study in Spain},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2024},
volume = {43},
number = {2},
pages = {279--296},
doi = {10.1007/s10096-023-04697-4}
}
EUVIMED